Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2461 AL 2475

A systematic review of carbohydrate-based bioactive molecules for Alzheimer's disease

Bajad NG, Swetha R, Gutti G, Singh M, Kumar A, Singh SK.

Future Med Chem. 2021 Oct;13(19):1695-1711. doi: 10.4155/fmc-2021-0109. Epub 2021 Sep 2.

Alzheimer's Disease: Efficacy of Mono- and Combination Therapy. A Systematic Review

Knorz AL, Quante A.

J Geriatr Psychiatry Neurol. 2022 Jul;35(4):475-486. doi: 10.1177/08919887211044746. Epub 2021 Sep 3.

Roles of microglia in Alzheimer's disease and impact of new findings on microglial heterogeneity as a target for therapeutic intervention

Takata K, Ginhoux F, Shimohama S.

Biochem Pharmacol. 2021 Oct;192:114754. doi: 10.1016/j.bcp.2021.114754. Epub 2021 Sep 1.

Extensive metabolism of flavonoids relevant to their potential efficacy on Alzheimer's disease

Xia H.

Drug Metab Rev. 2021 Nov;53(4):563-591. doi: 10.1080/03602532.2021.1977316. Epub 2021 Oct 1.

Breaker peptides against amyloid-β aggregation: a potential therapeutic strategy for Alzheimer's disease

Ghosh N, Kundu LM.

Future Med Chem. 2021 Oct;13(20):1767-1794. doi: 10.4155/fmc-2021-0184. Epub 2021 Sep 9.

Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer's Disease

Aaseth J, Skalny AV, Roos PM, Alexander J, Aschner M, Tinkov AA.

Int J Mol Sci. 2021 Aug 31;22(17):9461. doi: 10.3390/ijms22179461.

GPR40 Agonist Ameliorate Pathological Neuroinflammation of Alzheimer's Disease via the Modulation of Gut Microbiota and Immune System, a Mini-Review

Chen J, Li Q, Zhu J, Yuan Z, Wang T, Song J.

Neurotox Res. 2021 Dec;39(6):2175-2185. doi: 10.1007/s12640-021-00408-z. Epub 2021 Sep 10.

Effectiveness of the 10 cm(2) Rivastigmine Patch in Taiwanese Patients with Mild-to-Moderate Alzheimer's Dementia: A 48-Week Real-World Observational Study

Chang CC, Chan L, Chou HH, Yang YW, Chen TF, Chen TB, Chen CI, Yang A, Hu CJ.

Adv Ther. 2021 Oct;38(10):5286-5301. doi: 10.1007/s12325-021-01893-6. Epub 2021 Sep 10.

The oxidatively damaged DNA and amyloid-β oligomer hypothesis of Alzheimer's disease

Sanders OD, Rajagopal L, Rajagopal JA.

Free Radic Biol Med. 2022 Feb 1;179:403-412. doi: 10.1016/j.freeradbiomed.2021.08.019. Epub 2021 Sep 8.

Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease

Rapaka D, Bitra VR, Challa SR, Adiukwu PC.

Neuropeptides. 2021 Dec;90:102196. doi: 10.1016/j.npep.2021.102196. Epub 2021 Sep 2.

Aducanumab Fails to Produce Efficacy Results Yet Obtains US Food and Drug Administration Approval

Angelo M, Ward L.

Popul Health Manag. 2021 Dec;24(6):638-639. doi: 10.1089/pop.2021.0189. Epub 2021 Sep 13.

Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease

Abd-Elrahman KS, Ferguson SSG.

Annu Rev Pharmacol Toxicol. 2022 Jan 6;62:235-254. doi: 10.1146/annurev-pharmtox-021821-091747. Epub 2021 Sep 13.

Preclinical and clinical evidence of NAD(+) precursors in health, disease, and ageing

Reiten OK, Wilvang MA, Mitchell SJ, Hu Z, Fang EF.

Mech Ageing Dev. 2021 Oct;199:111567. doi: 10.1016/j.mad.2021.111567. Epub 2021 Sep 10.

Effects of Body Weight on the Safety of High-Dose Donepezil in Alzheimer's Disease: Post hoc Analysis of a Multicenter, Randomized, Open-Label, Parallel Design, Three-Arm Clinical Trial

Hong YJ, Han HJ, Youn YC, Park KW, Yang DW, Kim S, Kim HJ, Kim HJ, Lee Y, Kwon M, Lee JH; ODESA study (Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23 mg).

Dement Geriatr Cogn Disord. 2021;50(3):289-295. doi: 10.1159/000518470. Epub 2021 Sep 10.

Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer's Disease

Wan T, Fu M, Jiang Y, Jiang W, Li P, Zhou S.

Neurochem Res. 2022 Feb;47(2):205-217. doi: 10.1007/s11064-021-03448-1. Epub 2021 Sep 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias